QT prolongation induced by hydroxyzine: a pharmacovigilance case report
- 28 January 2015
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 71 (3) , 379-381
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effects of the histamine H1 receptor antagonist hydroxyzine on hERG K+ channels and cardiac action potential durationActa Pharmacologica Sinica, 2011
- Hydroxyzine, a First Generation H1-Receptor Antagonist, Inhibits Human Ether-a-go-go–Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG MutationJournal of Pharmacological Sciences, 2008
- Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT studyEuropean Journal of Clinical Pharmacology, 2007
- A simple high-performance liquid chromatographic method for detection of hydroxyzine in human plasma after overdoseJournal of Pharmacological and Toxicological Methods, 2004
- Risk of torsades de pointes with non-cardiac drugsBMJ, 2000